Align Technology Inc (ALGN)
271.50
-2.06
(-0.75%)
USD |
NASDAQ |
May 17, 16:00
271.43
-0.07
(-0.03%)
After-Hours: 20:00
Align Technology Cash from Financing (Quarterly): -11.72M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -11.72M |
December 31, 2023 | -350.28M |
September 30, 2023 | 11.83M |
June 30, 2023 | -0.931M |
March 31, 2023 | -258.96M |
December 31, 2022 | -200.19M |
September 30, 2022 | 10.90M |
June 30, 2022 | -200.65M |
March 31, 2022 | -111.74M |
December 31, 2021 | -101.57M |
September 30, 2021 | -65.00M |
June 30, 2021 | -238.32M |
March 31, 2021 | -53.44M |
December 31, 2020 | -2.448M |
September 30, 2020 | 8.016M |
June 30, 2020 | -1.643M |
March 31, 2020 | -34.73M |
December 31, 2019 | -102.38M |
September 30, 2019 | -194.78M |
June 30, 2019 | -95.62M |
March 31, 2019 | -92.76M |
December 31, 2018 | -54.28M |
September 30, 2018 | -144.41M |
June 30, 2018 | -30.92M |
March 31, 2018 | -139.82M |
Date | Value |
---|---|
December 31, 2017 | -56.46M |
September 30, 2017 | 5.204M |
June 30, 2017 | -51.24M |
March 31, 2017 | -33.00M |
December 31, 2016 | -37.90M |
September 30, 2016 | -2.111M |
June 30, 2016 | -46.40M |
March 31, 2016 | -9.106M |
December 31, 2015 | -11.83M |
September 30, 2015 | -14.03M |
June 30, 2015 | -67.83M |
March 31, 2015 | -7.097M |
December 31, 2014 | -19.50M |
September 30, 2014 | -1.051M |
June 30, 2014 | -66.93M |
March 31, 2014 | 21.06M |
December 31, 2013 | 10.73M |
September 30, 2013 | 12.99M |
June 30, 2013 | -77.32M |
March 31, 2013 | 15.42M |
December 31, 2012 | -36.61M |
September 30, 2012 | 10.54M |
June 30, 2012 | 21.99M |
March 31, 2012 | 14.29M |
December 31, 2011 | 2.852M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-350.28M
Minimum
Dec 2023
11.83M
Maximum
Sep 2023
-99.68M
Average
-80.31M
Median
Cash from Financing (Quarterly) Benchmarks
Boston Scientific Corp | 1.569B |
ResMed Inc | -335.91M |
Edwards Lifesciences Corp | 61.70M |
Stryker Corp | -418.00M |
Zimmer Biomet Holdings Inc | -50.10M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 28.66M |
Cash from Investing (Quarterly) | -79.58M |
Free Cash Flow | 491.58M |
Free Cash Flow Per Share (Quarterly) | 0.2562 |
Free Cash Flow to Equity (Quarterly) | 19.30M |
Free Cash Flow to Firm (Quarterly) | 19.30M |
Free Cash Flow Yield | 2.38% |